Product Program year 2025 Source: CMS Open Payments

Renal - Chronic

Device Renal

Open in the dashboard

General payments

$280,978

697 payments

Research payments

$403,900

5 payments

Through program year 2025, $280,978 in general payments and $403,900 in research payments were reported against Renal - Chronic (Renal).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $128,145 531
2025 Research $234,955 3
2024 General $4,353 63
2023 General $3,132 43
2022 General $11,382 36
2021 General $55,043 4
2021 Research $70,250 1
2020 General $51,190 4
2019 General $27,733 16
2019 Research $98,695 1

Breakdown

Who paid General payments · program years 2019–2025
  1. Baxter Healthcare $152,834 166 payments
  2. Vantive US Healthcare LLC $128,145 531 payments
Top recipients General payments · program year 2025
  1. University Of Alabama Hospital Teaching hospital · AL $23,695 18% · 1 payment
  2. Vikram Aggarwal Nephrology · Chicago, IL $16,032 13% · 11 payments
  3. Anjay Rastogi Nephrology · Los Angeles, CA $9,422 7% · 9 payments
  4. Osama El Shamy Nephrology · Nashville, TN $7,543 6% · 13 payments
  5. Anjali Saxena Nephrology · San Jose, CA $6,919 5% · 12 payments

The top 5 of 94 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nephrology Internal Medicine $86,824 83% · 71 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $6,242 6% · 7 practitioners
  3. Nurse Practitioner, Acute Care Nurse Practitioner $5,038 5% · 3 practitioners
  4. Internal Medicine $2,475 2% · 2 practitioners
  5. Nurse Practitioner $1,937 2% · 4 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Alabama $25,449 20% · 2 recipients
  2. California $19,586 15% · 6 recipients
  3. Illinois $16,477 13% · 2 recipients
  4. Pennsylvania $8,966 7% · 13 recipients
  5. Tennessee $8,633 7% · 2 recipients

The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

697 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record